When a patient reaches BMI 25, they are expected to begin challenging their dose with the prescriber
Authors: Astrup, A., Ludvik, B., Meincke, C., & Yildiz, B.Title: Efficacy and safety of oral semaglutide across subgroups in patients with obesity without diabetes: Journal: The Lancet Regional Health Europe , Volume 34, 2024, Article 100857 Gokul, P
It is illegal to sell or supply it in the UK, as it is unregulated, but, despite repeated warnings about the associated dangers and reported side-effects, some tanners continue to use it
High cost : Once approved, it will likely be costly like other popular weight loss drugs
At Vive Ageless Weight Loss Center, we understand the struggle many of our patients face with managing type 2 diabetes and weight-related health conditions